Significance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression

Kim,Soo‑Ah; Hong,Ran

doi:10.3892/ol.2014.1948

Significance of intracellular localization of survivin in cervical squamous cell lesions: Correlation with disease progression

Authors:
- Soo‑Ah Kim
- Ran Hong
View Affiliations

Affiliations: Department of Obstetrics and Gynecology, College of Medicine, Chosun University, Gwangju 501‑759, Republic of Korea, Department of Pathology, College of Medicine, Chosun University, Gwangju 501‑759, Republic of Korea
Published online on: March 7, 2014 https://doi.org/10.3892/ol.2014.1948
Pages: 1589-1593

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Survivin is a member of the inhibitor of apoptosis protein family. Under normal circumstances, survivin is expressed in embryonic and fetal tissues, but is completely downregulated in normal adult tissues. Notably, this protein has been found to be prominently expressed in a variety of human malignant tumors. The present study was designed to evaluate the possible role of survivin in the tumorigenesis of cervical intraepithelial neoplasia and invasive squamous cell carcinoma (SCC) of the uterine cervix. In addition, it was investigated whether the nuclear or cytoplasmic expression of survivin is associated with tumor progression. In total, 71 samples of cervical squamous tissue were obtained, including 15 normal squamous epithelia, 25 high‑grade squamous intraepithelial lesions (HSILs) and 31 SCCs, from cone biopsy and hysterectomy specimens and stained for survivin expression by immunohistochemistry. The intensity of survivin expression tended to increase with tumor progression (60.0% of normal mucosa, 76.0% of HSIL and 80.6% of SCC samples demonstrated high intensity survivin expression), but this correlation was not found to be statistically significant. However, a statistically significant difference was identified in the intracellular localization of survivin among the normal mucosa, HSIL and SCC samples (P<0.001). In total, 72% (18/25) of HSIL and 54.8% (17/31) of SCC cases expressed cytoplasmic staining in contrast to the nuclear staining of the normal mucosa. In addition, 64% (16/25) of HSIL and 42% (13/31) of SCC cases showed coexpression in the nucleus and cytoplasm. An inverse correlation was identified between the decrement of nuclear survivin expression and tumor progression, but was not statistically significant (P=0.08). These results indicated that analysis of the intracellular expression of survivin (particularly cytoplasmic expression) is a marker for predicting disease progression in the uterine cervix.

View Figures

View References

1	Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar
2	Barinaga M: Death by dozens of cuts. Science. 280:32–34. 1998. View Article : Google Scholar : PubMed/NCBI
3	Kiechle FL and Zhang X: Apoptosis: biochemical aspects and clinical implications. Clin Chim Acta. 326:27–45. 2002. View Article : Google Scholar : PubMed/NCBI
4	Crook NE, Clem RJ and Miller LK: An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol. 67:2168–2174. 1993.PubMed/NCBI
5	LaCasse EC, Baird S, Korneluk RG and MacKenzie AE: The inhibitors of apoptosis (IAPs) and their emerging role in cancer. Oncogene. 17:3247–3259. 1998. View Article : Google Scholar : PubMed/NCBI
6	Adamkov M, Výbohová D, Horáček J, Kovalská M and Furjelová M: Survivin expression in breast lobular carcinoma: correlations with normal breast tissue and clinicomorphological parameters. Acta Histochem. 115:412–417. 2013. View Article : Google Scholar
7	Li F, Yang J, Ramnath N, Javle MM and Tan D: Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer. 114:509–512. 2005. View Article : Google Scholar
8	Li F and Brattain MG: Role of the survivin gene in pathophysiology. Am J Pathol. 169:1–11. 2006. View Article : Google Scholar : PubMed/NCBI
9	Lee WS, Cho SB, Rew JS, Lee JH, Park CS and Joo YE: Expression of survivin in gastric carcinoma and its relation to tumor cell proliferation and apoptosis. Kor J Pathol. 43:329–334. 2009. View Article : Google Scholar
10	Ambrosini G, Adida C and Altieri DC: A novel anti-apoptotic gene, survivin, expressed in cancer and lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
11	Altieri DC: Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer. 81:61–70. 2008. View Article : Google Scholar : PubMed/NCBI
12	Mita AC, Mita MM, Nawrocki ST and Giles FJ: Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res. 14:5000–5005. 2008. View Article : Google Scholar : PubMed/NCBI
13	Hanahan D and Weinberg RA: The hallmarks of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
14	Adams JM and Cory S: Life-or-death decisions by the Bcl-2 protein family. Trends Biochem Sci. 26:61–66. 2001. View Article : Google Scholar
15	Qi G, Tuncel H, Aoki E, Tanaka S, Oka S, Kaneko I, et al: Intracellular localization of survivin determines biological behavior in colorectal cancer. Oncol Rep. 22:557–562. 2009.PubMed/NCBI
16	Tanaka K, Iwamoto S, Gon G, Nohara T, Iwamoto M and Tanigawa N: Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 6:127–134. 2000.PubMed/NCBI
17	Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, et al: Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 96:1921–1925. 2000.PubMed/NCBI
18	Monzó M, Rosell R, Felip E, Astudillo J, Sánchez JJ, Maestre J, et al: A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Onol. 17:2100–2104. 1999.PubMed/NCBI
19	Ikeguchi M, Ueta T, Yamane Y, Hirooka Y and Kaibara N: Inducible nitric oxide synthase and survivin messenger RNA expression in hepatocellular carcinoma. Clin Cancer Res. 8:3131–3136. 2002.
20	Wakana Y, Kasuya K, Katayanagi S, Tsuchida A, Aoki T, Koyanagi Y, et al: Effect of survivin on cell proliferation and apoptosis in gastric cancer. Oncol Rep. 9:1213–1218. 2002.PubMed/NCBI
21	Kawasaki H, Altieri DC, Lu CD, Toyoda M, Tenjo T and Tanigawa N: Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 58:5071–5074. 1998.PubMed/NCBI
22	Sarela AI, Macadam RC, Farmery SM, Markham AF and Guillou PJ: Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut. 46:645–650. 2000. View Article : Google Scholar
23	Sarela AI, Scott N, Ramsdale J, Markham AF and Guillou PJ: Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol. 8:305–310. 2001. View Article : Google Scholar
24	Sui L, Dong Y, Ohno M, Watanabe Y, Sugimoto K and Tokuda M: Survivin expression and its correlation with cell proliferation and prognosis in epithelial ovarian tumors. Int J Oncol. 21:315–320. 2002.
25	Okada E, Murai Y, Matsui K, Isizawa S, Cheng C, Masuda M and Takano Y: Survivin expression in tumor cell nuclei is predictive of a favorable prognosis in gastric cancer patients. Cancer Lett. 163:109–116. 2001. View Article : Google Scholar
26	Kennedy SM, O’Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD, et al: Prognostic importance of Survivin in breast cancer. Br J Cancer. 88:1077–1083. 2003. View Article : Google Scholar : PubMed/NCBI
27	Trieb K, Lehner R, Stulnig T, Sulzbacher I and Shroyer KR: Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol. 29:379–382. 2003. View Article : Google Scholar : PubMed/NCBI
28	Lehner R, Lucia MS, Jarboe EA, Orlicky D, Shroyer AL, McGregor JA and Shroyer KR: Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma. Appl Immunohistochem Mol Morphol. 10:134–138. 2002. View Article : Google Scholar
29	Tonini G, Vincenzi B, Santini D, et al: Nuclear and cytoplasmic expression of survivin in 67 surgically resected pancreatic cancer patients. Br J Cancer. 92:2225–2232. 2005. View Article : Google Scholar : PubMed/NCBI
30	Vischioni B, Van der Valk P, Span SW, Kruyt FA, Rodriguez JA and Giaccone G: Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lungcancer. Ann Oncol. 15:1654–1660. 2004. View Article : Google Scholar : PubMed/NCBI
31	Ito T, Shiraki K, Sugimoto K, Yamanaka T, Fujikawa K, Ito M, et al: Survivin promotes cell proliferation in human hepatocellular carcinoma. Hepatology. 31:1080–1085. 2000. View Article : Google Scholar : PubMed/NCBI
32	Grabowski P, Kühnel T, Mühr-Wilkenshoff F, Heine B, Stein H, Höpfner M, et al: Prognostic value of nuclear survivin expression in oesophageal squamous cell carcinoma. Br J Cancer. 88:115–119. 2003. View Article : Google Scholar : PubMed/NCBI
33	Tringler B, Lehner R, Shroyer AL and Shroyer KR: Immunohistochemical localization of survivin in serous tumors of the ovary. Appl Immunohistochem Mol Morphol. 12:40–43. 2004. View Article : Google Scholar : PubMed/NCBI
34	Birley HD: Human papillomaviruses, cervical cancer and the developing world. Ann Trop Med Parasitol. 89:453–463. 1995.PubMed/NCBI
35	American Cancer Society. Cancer Facts and Figures 1999. American Cancer Society; Atlanta, GA: 1999
36	Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 189:12–19. 1999. View Article : Google Scholar : PubMed/NCBI
37	Richart RM: Cervical intraepithelial neoplasia. Pathol Annu. 8:301–328. 1973.PubMed/NCBI
38	Wright TC, Kurman RJ and Ferenczy A: Precancerous lesions of the cervix. Blaustein’s Pathology of the Female Genital Tract. Kurman RJ: Springer-Verlag; New York, NY: pp. 229–232. 1994
39	Frost M, Jarboe EA, Orlicky D, Gianani R, Thompson LC, Enomoto T and Shroyer KR: Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol. 117:738–744. 2002. View Article : Google Scholar : PubMed/NCBI
40	Xie D, Zeng YX, Wang HJ, Wen JM, Tao Y, Sham JS and Guan XY: Expression of cytoplasmic and nuclear Survivin in primary and secondary human glioblastoma. Br J Cancer. 16:108–114. 2006. View Article : Google Scholar : PubMed/NCBI